ROTE WILLIAM E. (Senior Vice President, R&D) sold 10.2% of their position (12.45K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $409.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2026ACC: 0001698262-26-000001
Officer· Senior Vice President, R&D
Since Nov 2018
+61.21K
Net shares
Net buyer
$409.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
73.66K acquired · 12.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.09K
Price / share
—
Trade value
—
% of position
19.8%
1/31/2026
101.44K→121.53K
Common Stock
Direct
Shares
−12.45K
Price / share
$32.87
Trade value
$409.10K
% of position
10.2%
2/3/2026
121.53K→109.09K
Total
Net shares
+7.64K
Net value
-$409.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | A · Award | +20.09K | — | — | 19.8% | 101.44K | 121.53K |
| Common Stock Direct | 2/3/2026 | S · Sale | −12.45K | $32.87 | $409.10K | 10.2% | 121.53K | 109.09K |
| Total | +7.64K | -$409.10K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
53.57K shares
Shares
+53.57K
Strike price
33.095
Held after
53.57K
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock53.57K shares | 1/31/2026 | A · Award | +53.57K | 33.095 | — | 53.57K |